ADCY5 rs2768895: Understanding Your Genetic Result
The rs2768895 single-nucleotide polymorphism is a genetic variant situated within or near the ADCY5 gene, which encodes adenylate cyclase type 5. Research suggests this locus influences intracellular cyclic AMP signaling dynamics, particularly during catecholaminergic and acute metabolic stress responses. The current scientific evidence linking this specific variant to distinct clinical outcomes remains limited.
What each genotype means
Typical cAMP Signaling Kinetics
You carry two copies of the common T allele at rs2768895 in the ADCY5 gene. Research indicates this genotype is associated with baseline adenylyl cyclase activity and standard cyclic AMP signaling during metabolic or physiological stress. Evidence linking this specific common noncoding variant to measurable traits is limited, and it confers typical, population-average function.
Carried by approximately 56% of individuals in European-ancestry populations.
Intermediate Signaling Response
You carry one copy of the C allele and one copy of the T allele at rs2768895. Preliminary studies suggest that variation at this locus may subtly modulate cellular cyclic AMP kinetics during catecholamine exposure and metabolic regulation. Because overall clinical evidence remains limited, this genotype represents a minor statistical variation rather than a deterministic health risk.
Carried by approximately 38% of individuals in populations of European descent.
Altered cAMP Signaling Kinetics
You carry two copies of the C allele at rs2768895 within the ADCY5 locus. Genetic research suggests this genotype may be associated with altered kinetics of the cyclic AMP intracellular cascade during acute metabolic or catecholaminergic stress. Evidence for direct clinical consequences is currently limited, reflecting modest statistical shifts rather than an established diagnostic finding.
Carried by roughly 6% to 7% of individuals in European-ancestry cohorts.
Genomic Location and Variant Characteristics
The single-nucleotide polymorphism designated rs2768895 is located on chromosome 3 within the genomic locus encompassing the ADCY5 gene. In human reference assemblies mapped by databases such as dbSNP and Ensembl, the variant represents a base substitution involving cytosine (C) and thymine (T) alleles. Because this variation falls within a non-coding regulatory or intronic region, it does not alter the primary amino acid sequence of the encoded enzyme. Instead, variations in this chromosomal neighborhood often act as expression quantitative trait loci or modulate regulatory chromatin states. Research into this locus aims to elucidate whether non-coding differences influence transcription factor binding, alternative splicing, or tissue-specific gene expression levels.
The Biological Role of Adenylate Cyclase 5
The ADCY5 gene encodes adenylate cyclase 5, a membrane-bound enzyme responsible for converting adenosine triphosphate (ATP) into cyclic adenosine monophosphate (cAMP). As detailed in MedlinePlus Genetics and biomedical literature, cAMP is a ubiquitous second messenger that translates hormonal and neurotransmitter signals into intracellular cellular responses. Adenylate cyclase 5 is predominantly expressed in specific tissues, including the brain striatum, cardiovascular system, and pancreatic beta cells. In pancreatic tissue, cAMP generation is a critical step in glucose-stimulated insulin secretion. In the cardiovascular and nervous systems, it couples beta-adrenergic receptors to physiological adaptations during acute catecholaminergic surges, defining how cells respond to stress.
Current Research and Strength of Evidence
The evidence connecting the specific rs2768895 variant to clinical traits is currently categorized as limited. Genome-wide association studies cataloged by the NHGRI-EBI GWAS Catalog and biomedical literature have robustly implicated common regulatory polymorphisms in ADCY5 in fasting glucose regulation and type 2 diabetes risk. However, many reported associations in this region are driven by distinct lead variants in linkage disequilibrium. While experimental models indicate that alterations in ADCY5 signaling modulate cAMP kinetics under catecholaminergic and metabolic challenges, studies evaluating rs2768895 directly remain preliminary. The variant reflects subtle statistical shifts in cellular kinetics rather than a diagnostic marker of disease.
Population Frequency and Ancestral Distribution
According to genomic population frequency databases such as gnomAD and catalog cohorts, the minor allele at rs2768895 is the C allele. In populations of European ancestry, the C allele occurs at a minor allele frequency of approximately 0.25 (25%), meaning roughly 40% to 50% of individuals in these cohorts carry at least one C allele. Frequencies may vary across other global ancestral groups, including African, Asian, and Hispanic populations, where differences in linkage disequilibrium patterns alter the inheritance of surrounding regulatory variants. Because population-scale genomic data continues to expand, localized frequency estimates may be updated over time.
Interpreting Results in a Personal Health Context
Learning your rs2768895 genotype provides an educational look at common human genetic diversity rather than a medical evaluation. This single-nucleotide polymorphism is not a diagnostic test for any disorder, nor does it predict metabolic disease or treatment response on its own. Rare, severe coding mutations in ADCY5 can lead to childhood-onset movement disorders, but common variations like rs2768895 do not carry those implications. Consumers should not initiate, stop, or adjust prescription medications or dietary plans based on rs2768895 data. Any decisions regarding metabolic health, cardiovascular conditioning, or medication management should be discussed directly with a qualified healthcare provider.
How common is this variant?
The minor C allele exhibits a frequency of approximately 0.25 in cohorts of European ancestry, with the homozygous TT genotype being the most prevalent overall.
Frequently asked questions
Does having the rs2768895 variant mean I will develop diabetes?
No, having one or two copies of this variant does not mean you will develop diabetes. While the ADCY5 gene locus is involved in metabolic pathways and insulin signaling, rs2768895 is only weakly associated with statistical shifts in cellular kinetics, not clinical disease.
What is the biological role of the ADCY5 gene?
ADCY5 encodes the enzyme adenylate cyclase 5, which synthesizes cyclic AMP (cAMP) from ATP. This second messenger plays a crucial role in mediating cellular responses to hormones, stress signals, and glucose fluctuations.
Is rs2768895 related to rare ADCY5 movement disorders?
No, common single-nucleotide polymorphisms such as rs2768895 are distinct from the rare, high-impact pathogenic mutations that cause ADCY5-related dyskinesia. Common variants merely reflect normal human diversity.
Can I use my rs2768895 genotype to choose a diet or medication?
No, the current scientific evidence for rs2768895 is too limited to guide nutritional choices or pharmacotherapy. Any adjustments to your health regimen or medications should always be reviewed with a clinician or licensed pharmacist.
Sources & further reading
Educational information only, last refreshed 9/12/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2768895?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29